搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pig 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (PLCD4), partial CSB-YP840470PI
CSB-EP840470PI
CSB-BP840470PI
CSB-MP840470PI
CSB-EP840470PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Dehydrogenase/reductase SDR family member 4 (DHRS4) CSB-YP840471BO
CSB-EP840471BO
CSB-BP840471BO
CSB-MP840471BO
CSB-EP840471BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saimiri sciureus Non-secretory ribonuclease (RNASE2) CSB-YP840472SWD
CSB-EP840472SWD
CSB-BP840472SWD
CSB-MP840472SWD
CSB-EP840472SWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Delphinapterus leucas Cellular tumor antigen p53 (TP53) CSB-YP840473DJB
CSB-EP840473DJB
CSB-BP840473DJB
CSB-MP840473DJB
CSB-EP840473DJB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ateles geoffroyi Ribonuclease pancreatic (RNASE1) CSB-YP840474AVF
CSB-EP840474AVF
CSB-BP840474AVF
CSB-MP840474AVF
CSB-EP840474AVF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pongo pygmaeus Ribonuclease pancreatic (RNASE1) CSB-YP840475EXP
CSB-EP840475EXP
CSB-BP840475EXP
CSB-MP840475EXP
CSB-EP840475EXP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Myozenin-1 (MYOZ1) CSB-YP840476BO
CSB-EP840476BO
CSB-BP840476BO
CSB-MP840476BO
CSB-EP840476BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gorilla gorilla gorilla Cytochrome c oxidase subunit 8A, mitochondrial (COX8A), partial CSB-YP840477GGZ
CSB-EP840477GGZ
CSB-BP840477GGZ
CSB-MP840477GGZ
CSB-EP840477GGZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Probable U6 snRNA-associated Sm-like protein (ECU07_1830) CSB-YP840479EKH
CSB-EP840479EKH
CSB-BP840479EKH
CSB-MP840479EKH
CSB-EP840479EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Uncharacterized protein ECU01_0210/ECU01_1400 (ECU01_0210) CSB-YP840480EKH
CSB-EP840480EKH
CSB-BP840480EKH
CSB-MP840480EKH
CSB-EP840480EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi 40S ribosomal protein S3 (RPS3) CSB-YP840481EKH
CSB-EP840481EKH
CSB-BP840481EKH
CSB-MP840481EKH
CSB-EP840481EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Probable proteasome subunit alpha type-3 (PRE10) CSB-YP840482EKH
CSB-EP840482EKH
CSB-BP840482EKH
CSB-MP840482EKH
CSB-EP840482EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Cysteine desulfurase, mitosomal (NFS1) CSB-YP840483EKH
CSB-EP840483EKH
CSB-BP840483EKH
CSB-MP840483EKH
CSB-EP840483EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi V-type proton ATPase catalytic subunit A (VMA1), partial CSB-YP840484EKH
CSB-EP840484EKH
CSB-BP840484EKH
CSB-MP840484EKH
CSB-EP840484EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi 26S proteasome regulatory subunit RPN11 (RPN11) CSB-YP840485EKH
CSB-EP840485EKH
CSB-BP840485EKH
CSB-MP840485EKH
CSB-EP840485EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Probable proteasome subunit beta type-6 (PRE3) CSB-YP840486EKH
CSB-EP840486EKH
CSB-BP840486EKH
CSB-MP840486EKH
CSB-EP840486EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Probable glycerol-3-phosphate dehydrogenase (ECU10_0870), partial CSB-YP840487EKH
CSB-EP840487EKH
CSB-BP840487EKH
CSB-MP840487EKH
CSB-EP840487EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Inorganic pyrophosphatase (IPP1) CSB-YP840488EKH
CSB-EP840488EKH
CSB-BP840488EKH
CSB-MP840488EKH
CSB-EP840488EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Probable cell division control protein 7 homolog 1 (CDC7-1) CSB-YP840489EKH
CSB-EP840489EKH
CSB-BP840489EKH
CSB-MP840489EKH
CSB-EP840489EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi 60S ribosomal protein L10 (RPL10) CSB-YP840490EKH
CSB-EP840490EKH
CSB-BP840490EKH
CSB-MP840490EKH
CSB-EP840490EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>